ELISA catalogue navigation
Navigating IgG, IgA, IgE, and IgM ELISA Products
Immunoglobulin ELISA records can look similar while representing different analytes, species, subclasses, and documentation requirements. This guide presents a disciplined way to compare catalogue records before ordering, without treating a product name alone as evidence of suitability.
Class and subclass identity Species field Record comparison Controls and documentation Catalogue navigationThis is a catalogue-reading and experimental-planning guide. It does not infer antibody function, clinical significance, diagnostic meaning, or cross-species suitability from an analyte name. Product records should be reviewed with the supplier documentation and the requirements of the planned study.
01 · Identity before comparison
Class and subclass identity
“Immunoglobulin” is a broad catalogue concept, not a complete assay specification. IgG, IgA, IgE, and IgM are distinct immunoglobulin classes, while records such as IgG4 identify a subclass-level target. A useful first step is therefore to write the intended measurand in a controlled form before opening a product page: class or subclass + species + requested assay format. That simple expression helps prevent a search result for a related-sounding target from becoming an accidental substitute.
The class or subclass field should be read independently from the rest of the title. A record named for IgG4 should not be treated as a general IgG record merely because both contain “IgG.” Likewise, an IgE record should not be assumed to represent IgA, IgM, or total immunoglobulin. The catalogue name can identify the apparent target, but the product record and associated documentation remain the place to verify what is actually specified.
Class-level search
Use the class term when the project specifically calls for IgG, then check whether the record narrows the target to a subclass such as IgG4.
Target wording
Separate the analyte label from assumptions about sample type, biological role, or intended interpretation. Those details require documentation and study context.
Same class, different record
Two IgE records may still differ in species or other catalogue fields. A shared class name is a starting point for review, not a complete match.
Do not fill missing fields
If a record does not state a needed field in the material being reviewed, mark it for verification rather than inferring it from a related product.
Class, subclass, and catalogue language
For a comparison spreadsheet, use separate columns for “class,” “subclass,” and “record name.” This preserves the distinction between a normalized research requirement and the wording supplied by the catalogue. For example, Human IgG4 ELISA Kit is a record with the supplied target “Human IgG4,” while Human IgE ELISA Kit is a different record with the supplied target “IgE.” The names support catalogue identification; they do not, by themselves, establish that either record addresses a particular biological hypothesis or application.
This distinction becomes especially important when a search interface groups related products together. Grouping can help discovery, but it can also place class-level and subclass-level records next to each other. Before shortlisting, copy the exact product name, target field, species wording, catalogue number, and product URL into the project record. Retaining the original wording makes later review more auditable.
02 · Species is a decision field
Species field: treat it as explicit evidence
Species should be reviewed as its own selection criterion. A target name that appears familiar across records does not establish that an assay is appropriate for another species. Orthology, sequence differences, reagent recognition, matrix behavior, and the supplier’s stated documentation can all matter, but none should be inferred from a shared class label alone.
Start by recording the species named in the product title or target field. Next, compare it with the species represented in the planned samples. If those fields do not align, do not resolve the discrepancy by choosing the closest-looking record. Instead, identify the exact question that needs an answer: whether the supplier documents the intended species, whether the target is stated at the required level, and whether the assay documentation supports the planned sample context.
| Record | Catalogue number | Supplied target | Species wording | Review implication |
|---|---|---|---|---|
| Human IgG4 ELISA Kit | E-80G4 | Human IgG4 | Human | Review as a human, subclass-level record. |
| Human IgE ELISA Kit | E-80E | IgE | Human in product name | Keep class and species checks separate in the project table. |
| Pig IgA ELISA Kit | E-5A | IgA | Pig | Do not transfer the record to another animal species without supporting documentation. |
| Dog IgE ELISA Kit | E-40E | IgE | Dog | It shares an analyte class label with the human IgE record but is a separate species-specific record. |
The supplied records illustrate why the species column deserves prominence. The Human IgE ELISA Kit and Dog IgE ELISA Kit share the IgE label but identify different species in their names and have different catalogue numbers. That is enough to distinguish the records for navigation; it is not evidence that one can replace the other.
For broader discovery, the Human ELISA category and Animal ELISA category provide separate catalogue pathways. Category placement is useful for narrowing a search, but the final comparison should return to the individual product record and its documentation.
03 · A reproducible review method
Record comparison: compare fields, not impressions
A product shortlist is more useful when each candidate is reviewed against the same fields. Reading one record deeply and another only from a search-result title can create an uneven comparison. Use a fixed extraction template and mark unknowns explicitly. “Not stated in the reviewed record” is more defensible than a guessed value.
Define the request
Write the required immunoglobulin class or subclass, sample species, assay format, and any documentation fields that must be available before ordering.
Locate the record
Use the catalogue search and relevant category path, then open the canonical product page rather than relying on a shortened result label.
Extract exact fields
Copy the product name, catalogue number, target wording, species wording, stated application, and URL. Preserve capitalization and qualifiers.
Mark verification points
Separate fields that are explicitly documented from fields that require supplier confirmation or review of a technical document.
Shortlist transparently
Explain why a record remains under consideration and record why another was excluded. Do not describe an unverified candidate as interchangeable.
Recommended comparison fields
Exact product name, immunoglobulin class or subclass, target wording, and catalogue number.
Species stated in the record and the species represented by the planned samples.
Assay format or application as stated by the supplier. Do not expand “ELISA” into unprovided performance claims.
Available protocol, datasheet, validation notes, specifications, and any version or lot references that the project requires.
Questions still needing confirmation, such as sample context, required range, or other project-specific constraints.
Canonical product URL, review date, source document name, and the person responsible for the selection decision.
The catalogue records supplied for this guide offer clear navigation examples: Human IgG4, Human IgE, Pig IgA, and Dog IgE. They should be treated as distinct records even when the class label overlaps. The Human IgG4 record has catalogue number E-80G4; the Human IgE record has E-80E; the Pig IgA record has E-5A; and the Dog IgE record has E-40E. Recording catalogue numbers reduces the chance of confusing similarly named entries during procurement or later reporting.
04 · Interpretability begins before the plate
Controls and documentation
Catalogue navigation and experimental interpretation are connected by documentation. A product page may identify a target and application, but the planned work still needs a documented plate strategy. Before comparing results, define how blanks, standards, positive or negative controls, and replicates will be represented in the plate map. The exact control arrangement should follow the applicable protocol and the study design; this guide does not prescribe a universal layout.
A blank can help distinguish a signal associated with the assay system from signal in a sample-free well, but its role depends on how the assay is configured. Standards provide the reference observations used for the chosen calibration approach. Positive and negative controls, where specified and appropriate to the study, can provide additional checks on the run. Replicates make it possible to inspect variation within the planned run. These labels are not interchangeable, and they should be defined in the project’s plate plan rather than added retrospectively.
From product record to plate plan
What to document before ordering
- Target definition: Record whether the request is for a class, subclass, or another explicitly named target.
- Species requirement: Write the sample species separately from the target name and flag any mismatch for review.
- Assay context: Record that the supplier lists ELISA or another application, without assuming that the listing answers every study-specific question.
- Control plan: Identify the planned blanks, standards, controls, and replicates and link them to the relevant protocol or study document.
- Comparison boundary: State what can be compared across records and what cannot be concluded from the available catalogue fields.
- Traceability: Save the canonical URL, catalogue number, document version if supplied, and review date.
For readers building a broader quality workflow, the guide to ELISA controls and plate planning provides a related learning path. It should complement, not replace, the supplier’s current documentation and the project’s approved procedures.
Build a defensible shortlist
IgG, IgA, IgE, and IgM searches become easier to manage when the review separates identity, species, documentation, and study context. Start with the exact target, inspect the species field, compare records using the same template, and retain the catalogue number and canonical URL. Then document the controls and open questions that will govern the planned work. This approach supports efficient discovery without turning a product title into a claim about performance, function, clinical meaning, or cross-species suitability.